4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-020917
Chief Financial Officer acquired 9,018 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2018-03-16 | Other acquisition | +9,018 | 154,365 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…